Fig. 3
From: Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure
Serum XOR activity. Increased serum XOR activity was observed in the combined group of all sepsis patients (54.49 ± 57.09 mU/mL; n = 143), sepsis-only patients (43.76 ± 27.9 mU/mL; n = 68) or sepsis patients with ARDS (73.35 ± 64.91 mU/mL; n = 75) as compared to controls (20.85 ± 12.43 mU/mL; n = 31) (P = 1.96 × 10− 13, P < 0.0002 and P < 0.0001, respectively)